Tag: Dr. Christopher Still

The Connection Between Breast Cancer and Obesity

The Connection Between Breast Cancer and Obesity

| October 1, 2021

Christopher D. Still, DO, FACN, FACP, is the Co-clinical Editor of Bariatric Times; Medical Director for the Center for Nutrition and Weight Management, and Director for Geisinger Obesity Research Institute at Geisinger Medical Center in Danville, Pennsylvania. Dear Colleagues, As you all are aware, October is breast cancer awareness month, so I thought it was […]

Continue Reading

Weight Bias in a Weight Management Program?? You Bet!

Weight Bias in a Weight Management Program?? You Bet!

| September 1, 2021

by Christopher D. Still, DO, FACN, FACP Co-clinical Editor of Bariatric Times; Medical Director for the Center for Nutrition and Weight Management, and Director for Geisinger Obesity Research Institute at Geisinger Medical Center in Danville, Pennsylvania. Dear Colleagues, I know I have discussed this topic before, but after hearing an excellent lecture on weight bias […]

Continue Reading

What’s in your…Genes

What’s in your…Genes

| August 1, 2021

by Christopher D. Still, DO, FACN, FACP Co-clinical Editor of Bariatric Times; Medical Director for the Center for Nutrition and Weight Management, and Director for Geisinger Obesity Research Institute at Geisinger Medical Center in Danville, Pennsylvania. Dear Colleagues, As discussed on my June editorial message, semaglutide 2.4mg was FDA approved for the treatment of obesity, […]

Continue Reading

How to Evaluate Post-pandemic Weight Regain

How to Evaluate Post-pandemic Weight Regain

| July 1, 2021

by Christopher D. Still, DO, FACN, FACP Co-clinical Editor of Bariatric Times; Medical Director for the Center for Nutrition and Weight Management, and Director for Geisinger Obesity Research Institute at Geisinger Medical Center in Danville, Pennsylvania. Dear Colleagues, With the pandemic hopefully in our rearview mirror, we are left with most patients emerging with varying […]

Continue Reading

Semaglutide 2.4mg—One Giant STEP for Obesity Treatment??

Semaglutide 2.4mg—One Giant STEP for Obesity Treatment??

| June 1, 2021

by Christopher D. Still, DO, FACN, FACP Co-clinical Editor of Bariatric Times; Medical Director for the Center for Nutrition and Weight Management, and Director for Geisinger Obesity Research Institute at Geisinger Medical Center in Danville, Pennsylvania. Dear Colleagues, This is a very exciting time for clinicians treating obesity. Expected soon is the United States Food […]

Continue Reading

Encourage Your Patients to Attend YWM2021­—VIRTUAL!

Encourage Your Patients to Attend YWM2021­—VIRTUAL!

| May 1, 2021

by Christopher D. Still, DO, FACN, FACP Co-clinical Editor of Bariatric Times; Medical Director for the Center for Nutrition and Weight Management, and Director for Geisinger Obesity Research Institute at Geisinger Medical Center in Danville, Pennsylvania. Dear Colleagues, As we, healthcare providers, prepare and are excited about the upcoming American Society for Metabolic and Bariatric […]

Continue Reading

So What is an Obesity Medicine Specialist Anyway?

So What is an Obesity Medicine Specialist Anyway?

| April 1, 2021

by Christopher D. Still, DO, FACN, FACP Co-clinical Editor of Bariatric Times; Medical Director for the Center for Nutrition and Weight Management, and Director for Geisinger Obesity Research Institute at Geisinger Medical Center in Danville, Pennsylvania. Dear Colleagues, I am frequently asked by patients and physician colleagues, “What exactly is an Obesity Medicine Specialist (OMS) […]

Continue Reading

Turning Obstacles into Opportunities: Representing YOUR Patients during COVID-19

Turning Obstacles into Opportunities: Representing YOUR Patients during COVID-19

| March 1, 2021

by Christopher D. Still, DO, FACN, FACP Co-clinical Editor of Bariatric Times; Medical Director for the Center for Nutrition and Weight Management, and Director for Geisinger Obesity Research Institute at Geisinger Medical Center in Danville, Pennsylvania. Dear Colleagues, Like most people throughout the past year, the topic of COVID-19 continues to dominate media headlines, healthcare […]

Continue Reading

Obesity Treatment: “Supply and Demand” or “Demand and Supply”

Obesity Treatment: “Supply and Demand” or “Demand and Supply”

| February 1, 2021

by Christopher D. Still, DO, FACN, FACP Co-clinical Editor of Bariatric Times; Medical Director for the Center for Nutrition and Weight Management, and Director for Geisinger Obesity Research Institute at Geisinger Medical Center in Danville, Pennsylvania. Dear Colleagues, One thing we have learned from this last year with COVID-19 is that patients with obesity have […]

Continue Reading

Hello 2021!!! New Year’s Resolutions Have Never Been So Welcomed!!

Hello 2021!!! New Year’s Resolutions Have Never Been So Welcomed!!

| January 1, 2021

by Christopher D. Still, DO, FACN, FACP Co-clinical Editor of Bariatric Times; Medical Director for the Center for Nutrition and Weight Management, and Director for Geisinger Obesity Research Institute at Geisinger Medical Center in Danville, Pennsylvania. Dear Colleagues, With all that we have been through in 2020, the “COVID-15” has replaced the “Freshman-15” for a […]

Continue Reading